Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced that the European ...

Materials that encourage mineralization, mimicking the process in the human body, are becoming increasingly important in medicine and technology. This process, which occurs at the interface between ...